These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 1192556

  • 1. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL, Zivin JA, Kopin IJ.
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [Abstract] [Full Text] [Related]

  • 2. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P, Drolet G, Yamaguchi N, de Champlain J.
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [Abstract] [Full Text] [Related]

  • 3. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.
    Lamprecht F, Richardson JS, Williams RB, Kopin IJ.
    J Neural Transm; 1977 Dec; 40(2):149-58. PubMed ID: 323422
    [Abstract] [Full Text] [Related]

  • 4. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T, Winternitz SR, Lindheimer MD, Oparil S.
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [Abstract] [Full Text] [Related]

  • 5. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T, Hashimoto M.
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [Abstract] [Full Text] [Related]

  • 6. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P, de Champlain J, Yamaguchi N.
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [Abstract] [Full Text] [Related]

  • 7. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
    Chen YF, Nagahama S, Winternitz SR, Oparil S.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
    [Abstract] [Full Text] [Related]

  • 8. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
    Moreau P, Drolet G, Yamaguchi N, de Champlain J.
    Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
    [Abstract] [Full Text] [Related]

  • 9. Effects of acute and chronic administration of sotalol on the blood pressure and the sympathoadrenal activity of anesthetized deoxycorticosterone acetate-salt hypertensive rats.
    Bouvier M, de Champlain J.
    Can J Physiol Pharmacol; 1986 Sep; 64(9):1164-9. PubMed ID: 3779515
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased sympatho-adrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats.
    Bouvier M, de Champlain J.
    J Hypertens; 1986 Apr; 4(2):157-63. PubMed ID: 3011889
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W, Schömig A, Dietz R, Weber J, Gross F.
    Eur J Pharmacol; 1981 Nov 05; 75(4):255-63. PubMed ID: 7318911
    [Abstract] [Full Text] [Related]

  • 15. Peripheral and central catecholaminergic neurons in genetic and experimental hypertension in rats.
    Grobecker H, Saavedra JM, Roizen MF, Weise V, Kopin IJ, Axelrod J.
    Clin Sci Mol Med Suppl; 1976 Dec 05; 3():377s-380s. PubMed ID: 15756
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K, Masuyama Y.
    Am J Hypertens; 1991 Jan 05; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine.
    Lewis PJ, Dargie HJ, Dollery CT.
    Clin Sci Mol Med; 1975 Apr 05; 48(4):327-30. PubMed ID: 1126124
    [Abstract] [Full Text] [Related]

  • 19. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats.
    Fujita T, Sato Y.
    Am J Physiol; 1984 May 05; 246(5 Pt 2):F670-5. PubMed ID: 6144278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.